The global bioengineered protein drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market include the rising prevalence of chronic diseases, such as cancer and diabetes. These drugs are found to have relatively fewer side effects and are more effective as compared to other drugs. Moreover, with sensing the growing demand for bioengineered protein drugs, market players are increasing their investments towards the development of a wide range of products that include therapeutic proteins, vaccines, and monoclonal antibodies. This, in turn is expected to accelerate the growth of the global bioengineered protein drugs market during the forecast period.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bioengineered-protein-drugs-market
Furthermore, the other factor that is anticipated to fuel the market growth includes the rising demand for therapeutic proteins, which are projected to offer the highest value to the bioengineered protein drugs market during the forecast period. In addition, high adoption of these drugs is attributable to their competency to maintain the required protein levels in patients, and aid in the treatment of cancer, anaemia, hepatitis B/C, and haemophilia, among others, which in turn will boost the market growth. Besides this, the growing significance of preventive care in the healthcare sector is improving sales prospects for bioengineered protein drugs in vaccine formulations.
However, players operating in the global bioengineered protein drugs market are taking a cue and investing in the development of biosimilar and generic drugs that cost merely 20% of branded drugs. This is limiting the penetration of branded drugs in the Asia Pacific and leading to a surge in the popularity of generic ones, which is increasing the revenue potential of the bioengineered protein drugs market during the forecast period. Further, according to the National Health Commission, over 2,000 people died of infectious diseases such as cholera and plague in China, in August 2019. Such an alarming death rate is encouraging the adoption of therapeutics, especially in densely populated countries such as China and India, which is further contributing to the growth of the global bioengineered protein drugs market. Additionally, a huge geriatric population base seeking a cure for neurodegenerative diseases is further strengthening the position of the global bioengineered protein drugs market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Drug Type
o By Indication
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape: Johnson & Johnson Services, Inc., Sanofi S.A., and Amgen Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Bioengineered Protein Drugs Market Report by Segment
By Drug Type
- Monoclonal Antibodies
- Therapeutic Proteins
- Vaccines
By Indication
- Cancer
- Diabetes
- Autoimmune Diseases
- Infectious Diseases
- CVD
- Neurodegenerative Diseases
- Others
A full report of Bioengineered Protein Drugs Market is available at: https://www.omrglobal.com/industry-reports/bioengineered-protein-drugs-market
Bioengineered Protein Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Johnson & Johnson Services, Inc.
- Sanofi S.A.
- Amgen Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
